In BRAF-Mutated Advanced Melanoma, Range of First-line Choices Brings Hope, Questions

Source: AJMC, September 2021

A wave of new treatment strategies and therapeutic agents has transformed the prognosis for patients with BRAF-V600 mutation-positive metastatic melanoma, yet this new era has also created a need for better guidelines to help select the best treatment for each individual patient.

READ THE ORIGINAL FULL ARTICLE